Patient receives first infusion of Biogen's controversial Alzheimer's drug
A 70-year-old man from Rhode Island on Wednesday was the first to receive an infusion outside of a clinical trial of Biogen's...
Full Article
Patient receives first infusion of Biogen's controversial Alzheimer's drug
Upworthy
0 shares
1 views
You might like
Related news coverage
Stocks end mixed but Nasdaq powers to another record close
Proactive Investors
4.10pm Nasdaq closes at record high once again Wall Street as a whole ended mixed on Wednesday but the Nasdaq saw another record..
-
US stocks mixed at mid-session as traders get cautious on risk
Proactive Investors
-
Wall Street rises at the opening bell
Proactive Investors
-
The Petri Dish: Trump's FDA commissioner joins Flagship, first patient gets Aduhelm
bizjournals
-
Biogen's debated Alzheimer's drug given to first patient
Upworthy
Advertisement
More coverage
FDA Approves Highly Debated Alzheimer’s Drug
Newsy
Watch VideoGovernment health officials on Monday approved the first new drug for Alzheimer's disease in nearly 20 years,..
-
First patient receives controversial Biogen Alzheimer’s drug
Brisbane Times
-
First patient set to receive controversial Biogen Alzheimer' s drug
MENAFN.com
-
EXPLAINER: How will insurers cover a new Alzheimer's drug?
SeattlePI.com
-
FDA approves much-debated Alzheimer’s drug panned by experts
SeattlePI.com